HeartCore Signs 13th Go IPO Contract
18 Março 2024 - 5:05PM
HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or
the “Company”), a leading enterprise software and
consulting services company based in Tokyo, announced that it has
signed an agreement (“Consulting Agreement”) with PharmaBio
Corporation (“PharmaBio”) for its 13th Go IPO consulting service
win.
As compensation for its services, HeartCore expects to generate
from PharmaBio an aggregate of $500,000 in initial fees and
$300,000 in success fees. In addition, HeartCore has received a
warrant to acquire 3% of PharmaBio’s common stock, on a fully
diluted basis.
“I am pleased to announce our 13th Go IPO contract win and our
second contract for 2024,” said HeartCore CEO Sumitaka Kanno
Yamamoto. “With the recent $9 million generated from the sale of a
Go IPO client’s warrant, this business remains a pivotal driver for
our long-term financial growth and our ability to pursue M&A
opportunities within our software business. As our clients achieve
successful listings on U.S. exchanges, HeartCore is poised to reach
new heights, fueled by the revenue influx from the post-IPO sale of
additional Go IPO client warrants. Our team’s reputation and
services continue to solidify, establishing us as the preferred,
go-to U.S. IPO advisory firm within the Japanese markets. We look
forward to announcing our client’s successful listings and eagerly
await the financial benefits that will help stabilize and propel
the HeartCore business. Our team is confident that 2024 will be the
strongest year in company history.”
As part of the Consulting Agreement, HeartCore will assist
PharmaBio in its efforts to go public and list on the Nasdaq Stock
Market (“Nasdaq”) or the New York Stock Exchange (“NYSE”). Through
Go IPO, the Company services clients by assisting throughout the
audit and legal firm hiring process, translating requested
documents into English, assisting in the preparation of
documentation for internal controls required for an initial public
offering or de-SPAC, providing general support services, assisting
in the preparation of the S-1 or F-1 filing, and more.
About HeartCore Enterprises, Inc.Headquartered
in Tokyo, Japan, HeartCore Enterprises is a leading enterprise
software and consulting services company. HeartCore offers Software
as a Service (SaaS) solutions to enterprise customers in Japan and
worldwide. The Company also provides data analytics services that
allow enterprise businesses to create tailored web experiences for
their clients through best-in-class design. HeartCore’s customer
experience management platform (CXM Platform) includes marketing,
sales, service and content management systems, as well as other
tools and integrations, which enable companies to enhance the
customer experience and drive engagement. HeartCore also operates a
digital transformation business that provides customers with
robotics process automation, process mining and task mining to
accelerate the digital transformation of enterprises. HeartCore’s
GO IPOSM consulting services helps Japanese-based companies go
public in the U.S. Additional information about the Company's
products and services is available at
https://heartcore-enterprises.com/.
Forward-Looking StatementsAll statements other
than statements of historical facts included in this press release
are forward-looking statements. In some cases, forward-looking
statements can be identified by words such as “believed,” “intend,”
“expect,” “anticipate,” “plan,” “potential,” “continue,” or similar
expressions. Such forward-looking statements include risks and
uncertainties, and there are important factors that could cause
actual results to differ materially from those expressed or implied
by such forward-looking statements. These factors, risks, and
uncertainties are discussed in HeartCore’s filings with the
Securities and Exchange Commission. Investors should not place any
undue reliance on forward-looking statements since they involve
known and unknown, uncertainties and other factors which are, in
some cases, beyond HeartCore’s control which could, and likely will
materially affect actual results, and levels of activity,
performance, or achievements. Any forward-looking statement
reflects HeartCore’s current views with respect to future events
and is subject to these and other risks, uncertainties, and
assumptions relating to operations, results of operations, growth
strategy, and liquidity. HeartCore assumes no obligation to
publicly update or revise these forward-looking statements for any
reason, or to update the reasons actual results could differ
materially from those anticipated in these forward-looking
statements, even if new information becomes available in the
future. The contents of any website referenced in this press
release are not incorporated by reference herein.
HeartCore Investor Relations Contact: Gateway
Group, Inc.Matt Glover and John YiHTCR@gateway-grp.com(949)
574-3860
HeartCore Enterprises (NASDAQ:HTCR)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
HeartCore Enterprises (NASDAQ:HTCR)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025